GSK AND UNIVERSITY OF NORTH CAROLINA TO SEARCH FOR HIV CURE

摘要

GlaxoSmithKline (GSK) is establishing a research centre devoted to finding a cure for HIV/AIDS in partnership with the University of North Carolina at Chapel Hill, where the HIV Cure centre will be based. The two organisations have launched a new company Qura Therapeutics that will have responsibility for the business side of the partnership.